Yong Zou

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Transforming Growth Factor

Epithelial Mesenchymal Transition

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Shufang Liang, Yong Zou, Jingdong Gao, Xiaolin Liu, Wan-Fu Lin, Zifei Yin, Juan Du, Ya'ni Zhang, Qunwei Chen, Shu Li, Bin-Bin Cheng, Chang-Quan Ling
Corrigendum to "The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways". Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Qunwei Chen, Wan-Fu Lin, Zifei Yin, Yong Zou, Shufang Liang, Shanming Ruan, Peifeng Chen, Shu Li, Qi-Jin Shu, Bin-Bin Cheng, Chang-Quan Ling
Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)
Shufang Liang, Yong Zou, Jingdong Gao, Xiaolin Liu, Wan-Fu Lin, Zifei Yin, Juan Du, Ya'ni Zhang, Qunwei Chen, Shu Li, Bin-Bin Cheng, Chang-Quan Ling
The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)